Breast cancer injection wins backing of patients and UK health body
- POSTED: 25 Sep 2013 12:29
This graph is an experimental feature that tracks number of views over time.
The "wonder drug" trastuzumab (Herceptin) injection, designed for women with HER2-positive tumours, one of the most aggressive forms of the disease, wins UK health approval for treatment
Beating breast cancer could take all of five minutes, and more women are willing to take a shot at it.
The trastuzumab (herceptin) injection has won approval from UK health regulators for treatment among women battling aggressive breast cancer.
Cost-savings was one of the issues that won favour for the approval as well as time saved and a vast improvement to the quality of life of breast cancer patients whose treatments can last more than a year.
The injection which has to be administered regularly over 18 doses spread over a fortnight or a month, is an improvement over an intravenous drip of drugs.
Hailed as a "wonder drug" for breast cancer patients, the trastuzumab (Herceptin) injection is designed for women with HER2-positive tumours, one of the most aggressive forms of the disease.
In a UK trial of almost 600 women with early HER2-positive breast cancer, 45 per cent found their tumour eliminated compared to 41 per cent who received infusion treatments.
In a separate test conducted in France, more than 90 per cent of patients with HER-2–positive breast cancer said they preferred to be treated with trastuzumab injecttions rather than intravenous infusion.
Most cited the reduced time required for treatments as one of the benefits.
The French patients also said the injections were less painful and caused less irritation from bruising and to the injection site.
In Singapore, breast cancer is the number one affliction among women and is the main killer among women.
According to the Singapore Cancer Registry, Interim Report which tracked data from 2008 to 2012, breast cancer is also the main health risk among Chinese, Malay and Indian women.
To raise awareness and support for breast cancer programmes, the annual Pink Ribbon Walk will be held at the Marina Bay Waterfront Promenade on Saturday, 28 September.
The event is organised by Singapore's Breast Cancer Foundation.